FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours

Philipp Malle1, Manfred Sorschag, Hans-Jürgen Gallowitsch

  • 1Department of Nuclear Medicine and Endocrinology, PET-CT Center Klagenfurt, Klinikum Klagenfurt am Wörthersee, Feschnigstraße 11, 9020 Klagenfurt, Austria. philipp.malle@kabeg.at

Insights

Positron emission tomography (PET) scans using (18)F-fluorodeoxyglucose (FDG) aid in evaluating gastrointestinal stromal tumours (GISTs). FDG PET/CT imaging is valuable for diagnosis, recurrence detection, and assessing treatment response in GIST patients.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Gastrointestinal stromal tumours (GISTs) are rare malignancies, accounting for <3% of all GISTs.
  • Molecularly targeted therapies, like tyrosine kinase inhibitors, have transformed GIST management.
  • Malignant GISTs exhibit heightened glucose metabolism, leading to increased (18)F-fluorodeoxyglucose (FDG) uptake.

Purpose of the Study:

  • To elucidate the role of FDG PET and FDG PET/CT in GIST diagnosis and management.
  • To highlight the utility of dual-modality imaging for simultaneous functional and anatomical information.
  • To review the impact of FDG PET/CT in initial staging, recurrence detection, and treatment response assessment.

Main Methods:

  • Utilizing (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans.
  • Employing dual-modality FDG PET/CT imaging for integrated assessment.
  • Reviewing diagnostic and therapeutic applications in GIST patient management.

Main Results:

  • FDG PET/CT provides simultaneous functional and anatomical data crucial for GIST evaluation.
  • The imaging modality is valuable for initial disease assessment and detecting tumour recurrence.
  • FDG PET/CT enables early assessment of treatment response to targeted therapies like imatinib and sunitinib.

Conclusions:

  • FDG PET and FDG PET/CT imaging are integral tools in the comprehensive management of GISTs.
  • These imaging techniques offer significant value in diagnosis, monitoring recurrence, and evaluating therapeutic efficacy.
  • Dual-modality imaging enhances diagnostic accuracy and treatment monitoring for patients with GISTs.

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...